Beaconcure Inc., known for Verify, its secure online workspace for AI-enabled clinical study analysis validation, has partnered with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical trial review processes.
 
This partnership combines Beaconcure’s advanced technology with Phastar’s experience and vision in the clinical data analytics domain, to streamline clinical trial development and accelerate the delivery of lifesaving drugs.
 
Ilan Carmeli, Chief Operating Officer and Co-founder at Beaconcure, stated, “We are thrilled to collaborate with Phastar, a leader in clinical trial analytics. By leveraging Verify, Phastar is now equipped with a collaboration platform that reduces the potential for human error and increases efficiency and transparency, enabling faster study validation and approvals.”
 
Carmeli added, “By utilizing a unified platform, teams can integrate efforts, improve data integrity, and accelerate decision-making. These enhancements enable Phastar to manage internal communications and sponsor interactions more effectively, transforming clinical reviews, shortening review cycles, and expediting the delivery of treatments.”
 
Ping-Chung Chang, Head of Business Transformation and China General Manager at Phastar, remarked: “Integrating Beaconcure’s Verify platform into our processes is an impactful step and will help unlock further innovations across clinical data reporting, reviewing, and submission stages. We will utilize Verify to address critical areas in clinical review with automatically generated audit trails, streamlined data reporting delivery, and optimized workflow management.”
 
Through this partnership, Beaconcure and Phastar aim to explore new standards in the industry to increase speed and compliance in clinical trials, creating a dynamic system that learns and improves over time.